Articles

Poll

Podcasts

Slideshows

Videos

Sleep

On the HCPLive sleep page, resources on the topics of medical news and expert insight into sleep medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on sleep apnea, insomnia, narcolepsy, and more.

Late-breaking data at CHEST 2025 support the novel combination therapy, which may be submitted to the FDA in application for patients with OSA in coming months.

Aroxybutynin and Atomoxetine (AD109) Reduces Obstructive Sleep Apnea Burden in Phase 3 SynAIRgy

CHEST 2025 data suggest OSA is an "effect modifier" on the mortality benefit of GLP-1 receptor agonists in patients co-diagnosed with type 2 diabetes.

Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s

In this Q&A, Malhotra discusses how tirzepatide impacts obstructive sleep apnea treatment.

Tirzepatide’s Impact on OSA, With Atul Malhotra, MD

New research highlights the benefits of PAP therapy for sleep apnea, showing improvements in blood pressure and cardiometabolic health.

PAP Therapy for Sleep Apnea Linked to Improved Blood Pressure, With Harneet Walia, MD

Weeks discusses how tirzepatide is impacting treatment strategies for obstructive sleep apnea and driving collaboration across specialties.

Tirzepatide’s Role in Obstructive Sleep Apnea Care: Q&A With Brian Weeks, MD

FDA approval of tirzepatide for OSA sparks a surge in referrals as experts highlight weight loss benefits, symptom relief, and patient selection.

Tirzepatide Is A ‘Ray of Hope’ for Patients with OSA: Referral Uptick, Who Benefits

GLP-1 therapies support weight loss, but OSA requires dedicated airway treatment options such as CPAP or neuromuscular stimulation.

Helping Patients Sleep Better: Why the Airway Deserves Its Own Treatment Plan

At SLEEP 2025, HCPLive spoke to Strollo about the phase 3 SynAIRgy trial which evaluated AD109, a first-in-class, once-daily oral neuromuscular modulator, for OSA.

AD109 Improves OSA in Phase 3 SynAIRgy Trial, With Patrick Strollo, MD

At SLEEP 2025, Cassiere discussed how pulse oximetry inaccuracies among patients with darker skin tones may lead to underdiagnosis or misclassification of sleep apnea severity.

Racial Bias in Pulse Oximetry Skews Sleep Apnea Diagnoses, Warns Hugh Cassiere, MD

Findings highlight an increased risk of MASLD, heart failure, type 2 diabetes, and other cardiometabolic diseases following cycles of weight loss and regain.